All the news Showing 7 of 17 articles from: EASL 2020Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources New and experimental treatments for hepatitis B JNJ-3989 achieves sustained reductions in hepatitis B surface antigen Keith Alcorn / 29 August 2020 Johnson & Johnson’s short interfering RNA treatment for hepatitis B resulted in sustained reductions in hepatitis B surface antigen when combined with nucleoside analogue drugs, Professor Edward Gane of Auckland City Hospital, New ... New and experimental treatments for hepatitis B GSK antisense agent for hepatitis B shows promise Keith Alcorn / 29 August 2020 An antisense agent, GSK-3228836, significantly reduced hepatitis B surface antigen levels in previously untreated people with chronic hepatitis B after three injections, an early phase trial reported this week at the Digital International ... Hepatitis C elimination Only one in four high-income countries on track for hepatitis C elimination by 2030 Keith Alcorn / 28 August 2020 Only one in four high-income countries is on track to eliminate hepatitis C by 2030 and nearly two-thirds will miss the targets by more than 20 years at current rates of progress, ... Treatment for people living with HIV and HCV People with HIV do not have higher liver disease risk after hepatitis C treatment Keith Alcorn / 28 August 2020 People living with HIV do not have a higher risk of liver-related complications or death from liver disease after hepatitis C treatment with direct-acting antivirals, researchers from the French HEPAVIH cohort reported this ... NAFLD Novel methods of non-invasive testing for non-alcoholic fatty liver disease EASL / 28 August 2020 NAFLD Liver fibrosis assessment in routine care for diabetic patients could uncover a hidden population of people living with advanced liver disease EASL / 28 August 2020 Experimental treatments for NASH/NAFLD Two novel treatments show promise in improving biomarkers of NASH pathology EASL / 28 August 2020 ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive